Compound ID | 3664
Synonym(s): CHEMBL5555396 | orb3133341 | HY-162087 | CS-0926483
Class: Small molecule antibacterial agent
| Agent Type: | Synthetic; Small molecule; Direct acting; |
| Spectrum of activity: | Gram-negative |
| Mechanism of action: | Fatty acid synthesis inhibitor. FabH (Fatty acid biosynthesis: 3-oxoacyl-[acyl-carrier-protein] synthase III) |
| Target Pathogen: | Escherichia coli |
| Description: | Optimized FabH inhibitor from a medicinal chemistry SAR series targeting bacterial FAS-II pathway |
| Institute where first reported: | Ningbo Institute of Materials Technology and Engineering, Chinese Academy of Sciences |
| Year first mentioned: | 2024 |
| Highest development stage: | Preclinical |
| Development status: | Experimental |
| External links: | |
| Structure link: | https://pubchem.ncbi.nlm.nih.gov/compound/170453129 |
| Citation: | https://doi.org/10.1016/j.ejmech.2023.116064 |
| Patent: | CN114478474A |